Lotus Pharmaceutical Co., Ltd. (TPE:1795)
253.50
-14.50 (-5.41%)
At close: Mar 9, 2026
-2.69% (1Y)
| Market Cap | 66.67B |
| Revenue (ttm) | 18.66B |
| Net Income (ttm) | 4.73B |
| Shares Out | 262.98M |
| EPS (ttm) | 18.04 |
| PE Ratio | 14.05 |
| Forward PE | 9.61 |
| Dividend | 5.78 (2.16%) |
| Ex-Dividend Date | Aug 11, 2025 |
| Volume | 4,435,427 |
| Average Volume | 5,154,343 |
| Open | 255.00 |
| Previous Close | 268.00 |
| Day's Range | 250.50 - 260.00 |
| 52-Week Range | 172.50 - 369.50 |
| Beta | 0.28 |
| RSI | 31.06 |
| Earnings Date | Mar 13, 2026 |